Popular terms

[SEARCH]

Dimethyl topics
Physiologic
Hydrochloric Acid
Fresnel Zone
Aberration
Ophthalmic
Liquid Crystal
Imaging System
Pharmaceutically Acceptable Salt
Pharmaceutically Acceptable Salts
Chloric Acid
Tartaric Acid
Fumaric Acid
Antagonist
Bradykinin
Enantiomer

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Dimethyl patents



      
           
This page is updated frequently with new Dimethyl-related patent applications. Subscribe to the Dimethyl RSS feed to automatically get the update: related Dimethyl RSS feeds. RSS updates for this page: Dimethyl RSS RSS


Energy efficient method and apparatus for the extraction of biomolecules from dilute aqueous solution

Preparation of symmetrical and asymmetrical disulphides by reactive distillation of mixtures of disulphides


Date/App# patent app List of recent Dimethyl-related patents
07/30/15
20150214457 
 Thermoelectric material and thermoelectric module patent thumbnailnew patent Thermoelectric material and thermoelectric module
A thermoelectric material is manufactured by a manufacturing process including annealing at an annealing temperature from 125° c. To 200° c.
National Institute Of Advanced Industrial Science And Technology


07/30/15
20150211177 
 Press belt in a paper-making machine patent thumbnailnew patent Press belt in a paper-making machine
A press belt for a shoe-press device for dewatering or smoothing a fibrous web, in particular a paper, cardboard, or tissue web. The press belt has a fiber-reinforced plastic matrix.
Voith Patent Gmbh


07/30/15
20150210889 
 Method of applying an organosilane solution to rigid substrates and grout patent thumbnailnew patent Method of applying an organosilane solution to rigid substrates and grout
A stain-treated substrate comprising an extremely thin coating for stain protection. The stain-treated substrate includes substrate material and the extremely thin coating include a molecular layer of organosilane 3-(trimethoxysilyl) propyldimethyl octadecyl ammonium chloride covalently bonded to the surface of the substrate material.

07/30/15
20150210715 
 5,5-heteroaromatic anti-infective compounds patent thumbnailnew patent 5,5-heteroaromatic anti-infective compounds
The invention provides a series of 5,5-heteroaromatic compounds, syntheses thereof, compositions thereof, and methods of using such compounds and compositions. Various embodiments provide methods of killing and/or inhibiting the growth of m.
University Of Notre Dame Du Lac


07/30/15
20150210707 
 Crystals of dispiropyrrolidine derivatives patent thumbnailnew patent Crystals of dispiropyrrolidine derivatives
Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of mdm2 are provided. The present invention provides crystals of (3′r,4′s,5′r)-n-[(3r,6s)-6-carbamoyltetrahydro-2h-pyran-3-yl]-6″-chloro-4′-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2″-oxo-1″,2″-dihydrodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indole]-5′-carboxamide or a salt thereof which inhibits mdm2 and has anti-tumor activity.
Daiichi Sankyo Company, Limited


07/30/15
20150210638 
 Preparation of symmetrical and asymmetrical disulphides by reactive distillation of mixtures of disulphides patent thumbnailnew patent Preparation of symmetrical and asymmetrical disulphides by reactive distillation of mixtures of disulphides
The process of the invention is particularly suited to the preparation of dimethyl disulphide or diethyl disulphide from a mixture of symmetrical and/or asymmetrical dialkyl disulphides.. .

07/30/15
20150210618 
 Energy efficient  the extraction of biomolecules from dilute aqueous solution patent thumbnailnew patent Energy efficient the extraction of biomolecules from dilute aqueous solution
The present invention relates to the energy efficient and selective extraction of dilute concentrations of biomolecules, e.g., small organic compounds, e.g., one or more c2-c6 alcohols, one or more c3-c5 carboxylic acids, one or more c8-18 fatty alcohols, one or more c1-c18 dicarboxylic acids, one or more furfurals, one or more furans, one or more butanediols, one or more butadienes, and mixtures thereof, from an aqueous solution using liquid phase dimethyl ether (dme).. .
Phasex Corporation


07/30/15
20150210609 
 Ionic liquid alkylation of 1-butene to produce 2,5-dimethylhexane patent thumbnailnew patent Ionic liquid alkylation of 1-butene to produce 2,5-dimethylhexane
A process for producing dimethylhexanes (dmh) is provided. The dmh can be used to produce p-xylene.
Uop Llc


07/30/15
20150209321 
 Treatment of obesity using non-daily administration of 6-o-(4-dimethylaminoethoxy) cinnamoyl fumagillol patent thumbnailnew patent Treatment of obesity using non-daily administration of 6-o-(4-dimethylaminoethoxy) cinnamoyl fumagillol
The invention generally relates to methods of treating an overweight or obese subject, and treating overweight- or obesity-related conditions using non-daily administration of e.g, a metap-2 inhibitor.. .
Zafgen, Inc.


07/30/15
20150209318 
 Pharmaceutical compositions containing dimethyl fumarate patent thumbnailnew patent Pharmaceutical compositions containing dimethyl fumarate
Provided herein are compositions containing compounds, or pharmaceutically acceptable salts, that metabolize to monomethyl fumarate with certain pharmacokinetic parameters and methods for treating, prophylaxis, or amelioration of neurodegenerative diseases including multiple sclerosis using such compositions in a subject, wherein if the compositions contain dimethyl fumarate, the total amount of dimethyl fumarate in the compositions ranges from about 43% w/w to about 95% w/w.. .
Biogen Ma Inc.


07/30/15
20150209257 
new patent

Hair dye agent comprising aminopyrimidine derivatives


In which r1 is a c1-c4 alkyl group, r2 is a hydrogen atom, a c1-c8 alkyl group, a c2-c6 alkenyl group, a c1-c6 hydroxyalkyl group, a c2-c6 polyhydroxyalkyl group, a c1-c6 alkoxy group, a c1-c6 alkylamino group, a di-c1-c6 alkylamino group, a c1-c6 polyalkoxy group, a c1-c6 alkylamido-(c1-c6) alkyl group, wherein the amide function can be substituted by one or two groups x, or is an aryl group, y is an nh2 or an oh group, at least one coupler component selected from 3-amino-2-methylamino-6-methoxypyridine, 3-amino-6-methylphenol, 3-amino-2-hydroxypyridine, 1,3 -bis-(2,4-diaminophenoxy)propane, 2,7-dihydroxynaphthalene, 2-methylresorcinol, 2,5-dimethylresorcinol, 4-chlororesorcinol, 3-aminophenol, 2-amino-3-hydroxypyridine, 2-chloro-6-methyl-3-aminophenol, 2,6-dihydroxy-3,4-dimethylpyridine, 2-({3-[(2-hydroxyethyl)amino]-4-methoxy-5-methylphenyl}amino)ethanol, 2-({3-[(2-hydroxyethyl)amino]-2-methoxy-5-methylphenyl}amino)ethanol, 1-methoxy-2-amino-4-beta-hydroxy-ethylaminobenzene (lehmann's blue), 2,4-diaminophenoxyethanol, 5-amino-4-chloro-o-cresol, 2,4-dichloro-m-aminophenol, 2,6-dihydroxy-3,4-dimethylpyridine and/or a physiologically compatible salt of these compounds.. .

07/23/15
20150203514 

Methods of forming 4-chloro-2-fluoro-3-substituted-phenylboronic acid pinacol esters and methods of using the same


Methods include formation of 4-chloro-2-fluoro-3-substituted-phenylboronic acid pinacol esters. The method comprises contacting a 1-chloro-3-fluoro-2-substituted benzene with an alkyl lithium to form a lithiated 1-chloro-3-fluoro-2-substituted benzene.
Dow Agrosciences Llc


07/23/15
20150203507 

Method for preparing dialkyloxydianhyrohexitol by etherification of dianhydrohexitol using a light alcohol, in the presence of an acidic catalyst


A method for preparing a dialkyloxydianhyrohexitol (dimethylisosorbide) composition by etherification of dianhydrohexitol (isosorbide). The aim is to achieve a “clean” method that avoids the use of a methylation agent such as dimethyl sulfate or methyl chloride, which generates stoechiometric quantities of salts, or expensive dialkyl-carbonates, wherein only one of the two methyl groups participates in the preparation of mixed isosorbide ethers.
Universite Claude Bernard Lyon 1


07/23/15
20150202171 

Patch


A patch comprising a support layer and an adhesive layer, wherein the adhesive layer comprises diclofenac sodium, dimethyl sulfoxide, and citric acid; a mass ratio between the diclofenac sodium and the citric acid (mass of diclofenac sodium:mass of citric acid) is 1:0.15 to 1:0.45; and a mass ratio between the diclofenac sodium and the dimethyl sulfoxide (mass of diclofenac sodium:mass of dimethyl sulfoxide) is 1:0.75 to 1:3.. .
Hisamitsu Pharaceutical Co., Inc.


07/23/15
20150201615 

Insect repellent surface composition


Embodiments of the invention relate to a pest-control composition comprising at least one active ingredient and at least two other ingredients; wherein the at least one active ingredient is selected from the group consisting of geraniol, nootketone, amyl cinnamaldehyde, catnip, wintergreen, carvacrol, d-limonene, orange oil, lauric acid, alpha pinene, mint, cornmint oil, lemon oil, eucalyptus, eugenol, peppermint, lemongrass oil, and terpenes; and wherein the at least two other ingredients are selected from the group consisting of 2-propanol, alcohol, ethanol, monobutyl ether, ethylene glycol, terpenes, ethoxylated alcohol, dodecanol, ammonia, soap, lauryl polyglucose, polyethylene glycol, sodium lauryl sulfate, sodium olefin sulfonate, cocamidapropyl betaine, alkylbenzene sulfonate, polyoxyethelene alkylphenol sulfate, sodium dodecyl benzene sulfonate, sodium sterate, potassium sterate, potassium myristate, tomadol, polyglyceryl sterate, glycol monosterate, potassium oleate, polyglyceryl oleate, tween, polymers, acrylic polymers, ethyl cellulous, carboxymethyl cellulose, sodium hydroxide, ammonium hydroxide, polyacrylate polymer, polyvinyl pyrolidane, lauric diethanolamine, dimethyldodecylamine oxide, aspartic acid tetrasodium salt, and sodium citrate.. .
Tyratech, Inc.


07/16/15
20150197886 

Grafted para-aramid fiber and making


A method of making a fiber comprised of poly(p-phenylene terephthalamide) having monomer groups grafted onto the fiber surface, the method comprising the steps of (i) providing a fiber of poly(p-phenylene terephthalamide) that has been dried to remove adsorbed moisture, (ii) treating the fiber, in a non-polar solvent that will not dissolve the fiber, with a phosphazene base that exhibits a pka in dimethylsulfoxide of at least 21 so as to generate anions at the amide sites on the surface of the poly(p-phenylene terephthalamide) fiber, (iii) washing the base-activated fiber with an aprotic solvent, (iv) grafting a monomer onto the anion sites so as to introduce reactive functional groups onto the surface of the poly(p-phenylene terephthalamide) fiber, and (v) washing the grafted fiber of step (iv) with a protic solvent to extract any residual base compounds and grafting agents that are unbound to the surface of the fibers.. .
E I Du Pont De Nemours And Company


07/16/15
20150197544 

Compositions comprising enzyme-cleavable oxycodone prodrug


The embodiments provide compound kc-8, n-1-[3-(oxycodone-6-enol-carbonyl-methyl-amino)-2,2-dimethyl-propylamine]-arginine-glycine-malonic acid, or acceptable salts, solvates, and hydrates thereof. The present disclosure also provides compositions, and their methods of use, where the compositions comprise a prodrug, compound kc-8, that provides controlled release of oxycodone.
Signature Therapeutics, Inc.


07/16/15
20150196688 

Glycosaminoglycan and synthetic polymer material for blood-contacting applications


Provided herein is a composite, comprising: a polymer host selected from the group consisting of low-density polyethylene (ldpe), linear low-density polyethylene (lldpe), polyethylene terephthalate (pet), polytetrafluoroethylene (ptfe), and polypropylene (pp), polyurethane, polycaprolactone (pcl), polydimethylsiloxane (pdms), polymethylmethacrylate (pmma), and polyoxymethylene (pom); and a guest molecule comprising hyaluronic acid; wherein the guest molecule is disposed within the polymer host, and wherein the guest molecule is covalently bonded to at least one other guest molecule. Also provided herein are methods for forming the composite, and blood-contracting devices made from the composite, such as heart valves and vascular grafts..
Colorado State University Research Foundation


07/09/15
20150191747 

Microbial fermentation for the production of terpenes


The invention provides a method for producing a terpene or a precursor thereof by microbial fermentation. Typically, the method involves culturing a recombinant bacterium in the presence of a gaseous substrate whereby the bacterium produces a terpene or a precursor thereof, such as mevalonic acid, isopentenyl pyrophosphate, dimethylallyl pyrophosphate, isoprene, geranyl pyrophosphate, farnesyl pyrophosphate, and/or farnesene.
Lanza Tech New Zealand Limited


07/09/15
20150191666 

Process for producing renewable jet fuel compositions


Processes for producing jet fuel are disclosed. In one embodiment, syngas is converted to methanol, and a first portion of the methanol is converted to olefins using a methanol-to-olefins catalyst.

07/09/15
20150191414 

Process for the preparation of fluoroalkyl (alkyl carbonates and carbamates


Fluoroalkyl alkyl carbonates and fluorosubstituted carbamates which are suitable as additives or solvents in lithium ion batteries are prepared from fluoroalkyl fluoroformates and the respective alcohol or amine. Methanol is the preferred alcohol, dimethylamine and diethylamine are preferred amines.
Solvay Fluor Gmbh


07/09/15
20150190336 

Filaggrin gene expression promoter


The present invention provides a novel substance that promotes expression of filaggrin gene involved in improvement of the moisture retention function of skin. The inventors of the present invention found that expression of filaggrin gene fluctuates rhythmically over a roughly 24 hour cycle, screened candidate substances based on the time at which expression reaches a maximum following addition of the candidate substance, and identified zanthoxylum extract, 3-(1′-piperidine)propionic acid, geranium oil, cypress oil, rose oil, galvanum oil, pepper oil, basil oil, methyl-o-toluate, methyl anthranilate and dimethyl anthranilate as filaggrin gene expression promoting agents..
Shiseido Company, Ltd.


07/02/15
20150184001 

Fluoropolymer composition


The invention pertains to a fluoropolymer composition suitable for adhering a fluoropolymer coating onto a surface, in particular onto a metal surface, said composition comprising: at least one fluoropolymer [polymer (a)]; at least one aromatic polycondensation polymer [polymer (p)]; a solvent mixture [mixture (m)] comprising dimethylsulfoxide (dmso) and at least one solvent selected from the group consisting of diesters of formula (ide) and ester-amide of formula (1ea): r1—ooc-ade-coo—r2 (1de), r1—ooc-aea-co—nr3r4 (1ea) wherein: r1 and r2, equal to or different from each other, are independently selected from the group consisting of c1-c20 hydrocarbon groups; r3 and r4, equal to or different from each other, are independently selected from the group consisting of hydrogen, c1-c36 hydrocarbon groups, possibly substituted, being understood that r3 and r4 might be part of a cyclic n moiety including the nitrogen atom to which they are bound, said cyclic moiety being possibly substituted and/or possibly comprising one or more than one additional heteroatom, and mixtures thereof; ade and aea, equal to or different from each other, are independently a linear or branched divalent alkylene group, and to a method for coating a surface, specifically a metal surface, with a fluoropolymer, using said fluoropolymer composition.. .
Solvay Specialty Polymers Italy S.p.a.


07/02/15
20150183920 

Modified polyalkylene oxide


Wherein r2represents methyldiphenylene, hexamethylene, methyldicyclohexylene, 3-methyl-3,5,5-trimethylcyclohexylene, dimethylphenylene, or tolylene.. .

07/02/15
20150182572 

Plant extract and the process for treating hepatic fibrosis and liver cancer


An extract of graptopetalum paraguayense prepared by a method that includes: extracting a graptopetalum paraguayense (gp) starting material with an alcoholic solvent to produce an alcoholic extract and a residue; separating the residue from the alcoholic extract; extracting the residue with an aqueous dimethyl sulfoxide (dmso) solvent to produce a dmso extract; subjecting the dmso extract to ultrafiltration using a filter having a selected molecular weight cutoff; drying a fraction retained by the filter to obtain the extract of graptopetalum paraguayense. Uses of an extract of graptopetalum paraguayense for the treatment or prevention of liver fibrosis, hepatic cirrhosis, liver cancer, recurrence of liver fibrosis after surgery, or recurrence of liver cancer after surgery..
Development Center For Biotechnology


07/02/15
20150182540 

Drospirenone for hormone replacement therapy


A pharmaceutical composition comprising as a first active ingredient an estrogen, such as estradiol or estradiol valerate, in sufficient amounts to treat disorders and symptoms associated with deficient endogenous levels of estrogen in women, and as a second active ingredient 6β,7β;15β;16β-dimethylene-3-oxo-17α-preg-4-ene-21,17-carbolactone (drospirenone, drsp) in sufficient amounts to protect the endometrium from the adverse effects of estrogen is useful for, amongst others, treating peri-menopausal, menopausal and post-menopausal women. This composition may be used for hormone replacement therapy and may be administered as a multi-phased pharmaceutical preparation.
Bayer Intellectual Property Gmbh


06/25/15
20150179959 

Organic metal compound, organic light-emitting device employing the same, and preparing the same


Wherein one of r1 and r2 is hydrogen, and the other is trialkyl silyl group; and l is an acetylacetone ligand, a picolinate ligand, a 2-(imidazol-2-yl) pyridine ligand, a 2-(4,5-dimethyl-imidazol-2-yl)pyridine ligand, a 3-(trifluoromethyl)-5-(pyridine-2-yl)-1,2,4-triazolate ligand, or a 3-(tert-butyl)-5-(pyridine-2-yl)-1,2,4-triazolate ligand.. .

06/25/15
20150179316 

Methods of forming nitrides at low substrate temperatures


Provided are methods of forming nitrides at low substrate temperatures, such as less than 500° c. Or even less than 400° c.
Intermolecular Inc.


06/25/15
20150175873 

Oil recovery process, system, and composition


A system, composition, and process are provided for recovering oil from an oil-bearing formation. An oil recovery formulation comprising a polymer dispersed in a fluid that is at least 75 mol % dimethyl sulfide is introduced into an oil-bearing formation, and oil is produced from the formation..
Shell Oil Company


06/25/15
20150175843 

Multilayer film and molded body


A first multilayer film is a multilayer film which contains a layer a on at least one surface of a base film, in which the layer a has (1) a polycaprolactone segment, (2) a polysiloxane segment and/or a polydimethyl siloxane segment, and (3) a urethane bond, and the layer a has a glass transition temperature of from −30 to 0° c. A second multilayer film contains a layer a on at least one surface of a base film, in which the layer a has a scratch recovery time of 3 seconds or less at a temperature of 10° c.
Toray Industries, Inc.


06/25/15
20150175740 

Processing-friendly dianhydride hardener for epoxy resin systems based on 5,5'-carbonylbis(isobenzofuran-1,3-dione)


The present invention provides a composition comprising 5,5′-carbonylbis(isobenzofuran-1,3-dione), 3,3′,4,4′-benzophenonetetracarboxylic acid and at least one monoanhydride compound selected from the group consisting of methylhexahydroisobenzofuran-1,3-dione, 5-methyl-3a,4,7,7a-tetrahydro-4,7-methanoisobenzofuran-1,3-dione, 5-methyl-3a,4,7,7a-tetrahydroisobenzofuran-1,3-dione, 3-methylfuran-2,5-dione, 3,3,4,4,5,5-hexafluorodihydro-2h-pyran-2,6(3h)-dione and 3,3-dimethyldihydrofuran-2,5-dione. The invention also provides a hardener system for an epoxy resin, said hardener system comprising said composition.
Evonik Industries Ag


06/25/15
20150175738 

Processing-friendly dianhydride hardener for epoxy resin systems based on 5,5'-oxybis(isobenzofuran-1,3-dione)


The present invention provides a composition comprising 5,5′-oxybis(isobenzofuran-1,3-dione), 4,4′-oxybis(ortho-phthalic acid) and at least one monoanhydride compound selected from the group consisting of methylhexahydroisobenzofuran-1,3-dione, 5-methyl-3a,4,7,7a-tetrahydro-4,7-methanoisobenzofuran-1,3-dione, 5-methyl-3 a,4,7,7a-tetrahydroisobenzofuran-1,3-dione, 3-methylfuran-2,5-dione, 3,3,4,4,5,5-hexafluorodihydro-2h-pyran-2,6(3h)-dione, and 3,3-dimethyldihydrofuran-2,5-dione. The invention also provides a hardener system for epoxy resins, said hardener system comprising said composition.
Evonik Industries Ag


06/25/15
20150175512 

Method for starting up a dme synthesis reactor


A method for starting up a dme synthesis reactor in which methanol is converted by dehydration to dimethyl ether on a solid catalyst, wherein the catalyst is heated up with condensing methanol vapor, possibly in several steps. In a final treatment step with superheated methanol vapor, the catalyst is dried and its temperature is raised to the starting temperature of the methanol dehydration..
L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes George


06/25/15
20150175499 

Conversion of methanol to olefins and para-xylene


Methods are provided for conversion of methanol and/or dimethyl ether to aromatics, such as a para-xylene, and olefins, such as ethylene and propylene. The methods can be used in conjunction with molecular sieve (zeolite) catalysts that are prepared for use in conjunction with selected effective conversion conditions.
Exxonmobil Chemical Patents Inc.


06/25/15
20150174567 

Hybrid photocatalyst for wastewater remediation


The hybrid photocatalyst for wastewater remediation is a composite of rhodamine b and biobr. The rhodamine b has a concentration between about 0.1 wt % and about 1 wt % of the overall photocatalyst.
King Fahd University Of Petroleum And Minerals


06/25/15
20150174563 

Bound catalyst for selective conversion of oxygenates to aromatics


A catalyst composition includes a zeolite, a binder, and a group 12 transition metal selected from the group consisting of zn, cd, or a combination thereof, the zeolite having a silicon to aluminum ratio of at least about 10, the catalyst composition comprising about 50 wt % or less of the binder based on a total weight of the catalyst composition, the catalyst composition having a micropore surface area of at least about 340 m2/g, a molar ratio of group 12 transition metal to aluminum of about 0.1 to about 1.3, and at least one of (a) a mesoporosity of greater than about 20 m2/g; (b) a diffusivity for 2,2-dimethylbutane of greater than about 1×10−2 sec−1 when measured at a temperature of about 120° c. And a 2,2-dimethylbutane pressure of about 60 torr (about 8 kpa)..
Exxonmobil Research And Engineering Company


06/25/15
20150174562 

Alumina bound catalyst for selective conversion of oxygenates to aromatics


A catalyst composition comprising a zeolite, an alumina binder, and a group 12 transition metal selected from zn and/or cd, the zeolite having a si/al ratio of at least about 10 and a micropore surface area of at least about 340 m2/g, the catalyst composition comprising about 50 wt % or less of the binder, based on a total weight of the catalyst composition, and having a micropore surface area of at least about 290 m2/g, a molar ratio of group 12 transition metal to aluminum of about 0.1 to about 1.3, and at least one of: a mesoporosity of about 20 m2/g to about 120 m2/g; a diffusivity for 2,2-dimethylbutane of greater than about 1×10−2 sec−1 when measured at a temperature of about 120° c. And a 2,2-dimethylbutane pressure of about 60 torr (8 kpa); and a combined micropore surface area and mesoporosity of at least about 380 m2/g..
Exxonmobil Research And Engineering Company


06/25/15
20150174561 

Catalyst for selective conversion of oxygenates to aromatics


A catalyst composition comprises a self-bound zeolite and a group 12 transition metal selected from the group consisting of zn, cd, or a combination thereof, the zeolite having a silicon to aluminum ratio of at least about 10, the catalyst composition having a micropore surface area of at least about 340 m2/g, a molar ratio of group 12 transition metal to aluminum of about 0.1 to about 1.3, and at least one of: (a) a mesoporosity of greater than about 20 m2/g; (b) a diffusivity for 2,2-dimethylbutane of greater than about 1×10−2 sec−1 when measured at a temperature of about 120° c. And a 2,2-dimethylbutane pressure of about 60 torr (about 8 kpa)..
Exxonmobil Research And Engineering Company


06/25/15
20150174140 

Method for on-demand contraception


The invention relates to a method for on-demand contraception, which method comprises administering a progestogen agent or progesterone receptor modulator, such as 17a-acetoxy-11b-(4-n,n-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-dione (ulipristal acetate) in a woman, within 72 hours before an intercourse or within 120 hours after the intercourse.. .
The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv


06/25/15
20150174135 

Flavanoid compounds and process for preparation thereof


The present invention relates to flavanoid compounds of general formula (x1) wherein: r1 is selected from a group consisting of morpholinyl, n-methyl piperizinyl, piperidinyl and n,n′-dimethylamino groups, and n ranges from 3 to 6, and process for preparation thereof. The present invention relates to the demonstration of anti helicobacter pylori activity and gastric antisecretory activity of semisynthetically designed flavonoid compounds, to be used for the prevention and treatment of gastroduodenal disorders in general and peptic ulcer diseases in particular.
Council Of Scientific & Industrial Research


06/18/15
20150171474 

Lithium-ion secondary battery and electrolyte thereof


The present disclosure provides a lithium-ion secondary battery and an electrolyte thereof. The electrolyte of the lithium-ion secondary battery comprises a lithium salt; a non-aqueous solvent and an additive.
Ningde Amperex Technology Limited


06/18/15
20150171473 

Lithium-ion secondary battery and electrolyte thereof


The present disclosure provides a lithium-ion secondary battery and an electrolyte thereof. The electrolyte comprises a lithium salt; a non-aqueous solvent and an additive comprising a first additive and a second additive, the first additive comprises at least one of vinylene carbonate and vinyl ethylene carbonate, the second additive is 4-methylene-1,3-dioxolan-2-one and its derivatives with a structural formula 1 and/or 4,5-dimethylene-1,3-dioxolan-2-one and its derivatives with a structural formula 2; in the structural formula 1 and the structural formula 2, r1, r2, r3 and r4 each are hydrogen, halogen, c1˜c3 alkyl or halogenated alkyl; a weight percentage of the first additive in the electrolyte is 0.2%˜2.0%, a weight percentage of the second additive in the electrolyte is 0.3%˜4.0%.
Ningde Amperex Technology Limited


06/18/15
20150171288 

Light-emitting device and organic-inorganic hybrid pre-polymer composition comprising phosphor


A solid light-emitting device comprising a light-emitting semiconductor element and a phosphor dispersed in a sealant, in which the phosphor is exited by the light emitted by the semiconductor element to emit a visible light of a wavelength differing from that of the light emitted by the semiconductor element and is a silicate phosphor or a phosphor having a hydroxyl group on its surface, and the sealant is a condensation product of a prepolymer produced by condensation of polydimethyl-siloxane having a silanol group at both ends and an oligomer of an alkoxide of a metal or a semimetal or its derivative.. .
Ube Material Industries, Ltd.


06/18/15
20150166865 

Refrigerant mixtures


Use of a gaseous mixture, selected from the group consisting of:—dimethyl ether in a concentration from 85% to 95% by weight and propylene in a concentration from 5% to 15% by weight, and—dimethyl ether in a concentration from 71% to 85% by weight and propane in a concentration from 15% to 29% by weight as a replacement or alternative refrigerant for r134a and/or for other refrigerants which are replacements or alternatives to r134a containing hfc (hydrofluorocarbons), hfo (hydrofluoro olefins) and hfe (hydrofluoro ethers).. .
Tazzetti S.p.a


06/18/15
20150166752 

Polymeric foam


The present invention relates to composition for the preparation of a polymeric foam with improved thermal properties, to a polymeric foam obtainable therefrom, and to a method for preparing such a polymeric foam each for them comprising (i) an at least essentially amorphous polymer resin and (ii) a nucleating agent. The at least essentially amorphous polymer resin is preferably polystyrene.
Clariant International, Ltd.


06/18/15
20150166519 

Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4] oxadiazol-5-yl]-3-nitrobenzene-1,2-diol


This invention relates to novel polymorphs of (ho)2no2(c6h)—(c2n2o)—(c5n)(ch3)2cl2o, to processes for their preparation, and to pharmaceutical compositions containing said novel polymorphs as active pharmaceutical ingredient.. .
Bial - Portela & Ca., S.a. ("portela")


06/18/15
20150165125 

Lubricant coating and medical injection device comprising such a coating


The invention relates to a lubricant coating (5) for a medical injection device (1), comprising successively: —a bottom layer (50) in contact with the medical device surface (21) of the container to be lubricated, comprising a mixture of cross-linked and non-cross-linked poly-(dimethylsiloxane), —an intermediate layer (51) consisting essentially of oxidized poly-(dimethylsiloxane) and having a thickness comprised between 10 and 30 nm and, —a top layer (52) consisting essentially of non-cross-linked poly-(dimethylsiloxane) and having a thickness of at most 2 nm. The invention also relates to a medical injection device comprising such a lubricant coating, and a manufacturing process for said coating..
Becton Dickinson France


06/18/15
20150164849 

Combination therapy for treatment of multiple sclerosis


The present invention relates to a method of treating ms in a human patient in need of such treatment and comprises administering to said patient a combination therapy in a single oral dosage form (e.g. A tablet or capsule) of dim ethyifurrta rate and one agent selected from teriflunomide (or its prodrug leflunomide), fingolimod and laquinimod.
Forward Pharma A/s


06/11/15
20150159009 

Graft copolymers, their preparation and use in capillary electrophoresis


The invention relates to graft copolymers, their preparation, and compositions, such as electrophoresis separation media, containing the same; also to ultra-high molecular weight poly(n,n-dimethylacrylamide) (“poly(dma)”) polymers, their preparation, and compositions, such as electrophoresis separation media, containing the same; and more particularly to supports, such as capillaries, containing these polymers and methods for separating biomolecules, especially polynucleotides, using capillary electrophoresis. The graft copolymers can be prepared by, e.g., grafting polyacrylamide units onto a poly(dma) backbone.
Applied Biosystems, Llc


06/11/15
20150158893 

Process for preparing malathion for pharmaceutical use


The present invention provides a process for preparing a highly pure form of malathion having a reduced level of toxic impurities. In addition, the malathion prepared by the process of this invention is storage stable.
Taro Pharmaceuticals North America, Inc.


06/11/15
20150158849 

Solid salt forms of a pyrrole substituted 2-indolinone


The present invention relates to solid salt forms of the 3-pyrrole substituted 2-indolinone compound 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3z)-ylidenemethyl]-2,4-dimethyl-1h-pyrrole-3-carboxylic acid (2-pirrolidin-1-yl-ethyl)-amide. It also relates to polymorphs of the phosphate salt of the amide.
Zoetis Llc


06/11/15
20150158798 

Process for producing 4-cyclohexyl-2-methyl-2-butanol


The present invention relates to the field of perfumery. More particularly, it concerns a process for the preparation of 2-methyl-4-phenyl-2-butanol, or even 4-cyclohexyl-2-methyl-2-butanol from 4,4-dimethyl-2,6-diphenyl-1,3-dioxane..
Firmenich Sa


06/11/15
20150158275 

Non-yellowing glass laminate structure


A glass laminate structure comprising an internal glass sheet, an external glass sheet, and at least one polymer interlayer intermediate the external and internal glass sheets where the polymer interlayer includes a phenol, 2-(2h-benzotriazol-2-yl)-4,6-bis(1,1-dimethylpropyl) additive, a 2-(2h-benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl)phenol additive, a 2-(2h-benzotriazol-2-yl)-6-(1-methyl-1-phenylethyl)-4-(1,1,3,3-tetramethylbutyl)phenol additive, or an hydroxyphenyl substituted benzotriazole additive without a chlorine substituent. In some embodiments, the external and/or internal glass sheets can be formed from non-chemically strengthened glass, and in other embodiments, the external and/or internal glass sheets can be formed from chemically strengthened glass.
Corning Incorporated


06/11/15
20150157729 

Topical composition comprising a film-forming polymer for delivering an active ingredient to skin


A sprayable film-forming pharmaceutical composition for dermal application comprises at least one therapeutically active ingredient dissolved in a pharmaceutically acceptable propellant selected from the group consisting of dimethyl ether, diethyl ether and methylethylether, and a mixture of dimethyl ether, diethylether and methylethyl ether, and a second propellant selected from c3-5 alkanes, hydrofluoroalkanes, hydrochloroalkanes, fluoroalkanes and chlorofluoroalkanes, the propellant being present in an amount of 50-99.5% w/w of the composition, the composition further comprising a film-forming polymer, a plasticizer and an oily release-enhancing agent.. .
Leo Pharma A/s


06/11/15
20150157640 

Novel compounds


Wherein r1 is 2-indanyl, r2 is 1-methylpropyl, r3 is a group selected from 2,6-dimethyl-3-pyridyl or 4,6-dimethyl-3-pyridyl, r4 represents methyl and r5 represents hydrogen or methyl or, r4 and r5 together with the nitrogen atom to which they are attached represent morpholino and pharmaceutically acceptable derivatives thereof are described, as are processes for their preparation, pharmaceutical compositions containing them and their use in medicine, particularly their use as oxytocin antagonists.. .

06/11/15
20150157046 

Nutritional product composition for the mind


A nutritional product composition for the mind to support mental performance and alertness, promote superior cognitive function, support focus, attention and memory, help with age-related declines in learning, organization and concentration, and help protect a user's brain from free radical damage. The nutritional product composition for the mind includes a synergistic blend of nutrients and a silica gel that increases the rate of metabolism of cells to increase the rate of absorption of the nutrients and increase levels of acetylcholine rapidly.
Lifewave, Inc.


06/04/15
20150152351 

Perfume composition for reproducing fragrance of abies koreana of jeju island


Provided is a perfume composition having excellent acceptability and also reproducing the distinct fragrance of abies koreana of jeju island by adding trans-4,8-dimethyl-1,3,7-nonatriene to limonene, linalool, and myrcene, that are analyzed as the fragrance ingredients of abies koreana of jeju island by a spme method.. .
Amorepacific Corporation


06/04/15
20150152100 

Solvate form m of trametinib dimethyl sulfoxide and methods of making and using thereof


The present invention relates to a crystalline form m of trametinib dimethyl sulfoxide solvate. Comparing with the prior art, form m is a more stable crystalline form with better particle size distribution and good flowability and is non-hygroscopic.
Hangzhou Pushai Pharmaceutical Technology Co., Ltd.


06/04/15
20150150867 

Compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine


Pharmaceutical compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine and pharmaceutically acceptable acid addition salts thereof adapted so that release does not take place in the stomach is provided.. .
H. Lundbeck A/s


06/04/15
20150150260 

Diuron-containing thinners


The present invention relates to a thinning method, in particular for fruit thinning, using 3-(3,4 -dichlorophenyl)-1,1-dimethylurea (diuron), and to thinning compositions comprising diuron.. .
Lanxess Distribution Gmbh


05/28/15
20150148540 

Methods for the synthesis of tiotropium bromide


Present invention relates to methods for preparing (1α,2β,4β,5α,7β)-7-[(hydroxidi-2-thienllacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane-bromide.. .

05/28/15
20150148474 

Photosensitive resin composition and antireflection film


[problem] to provide: a photosensitive resin composition which is cured by radiation and exhibits excellent wear resistance, antifouling properties, marker pen ink wiping-off properties, fingerprint wiping-off properties and low refractive index, and which provides low reflectance in cases where the photosensitive resin composition is used for an antireflection film; and an antireflection film which has a cured coating film of this photosensitive resin composition. [solution] a photosensitive resin composition for an antireflection film that is characterized in that a low refractive index layer contains an acrylate, a colloidal silica, and an organic modified dimethyl polysiloxane having an acryloyl group and an acrylate-modified perfluoropolyether that serve as surface modification agents; and an antireflection film which is obtained by curing the photosensitive resin composition..
Polatechno Co., Ltd.


05/28/15
20150148292 

Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto


The disclosure relates to compounds and compositions for bone formation, fracture treatment, bone grafting, bone fusion, cartilage maintenance and repair, and methods related thereto. In certain embodiments, the disclosure relates to compositions comprising one or more compound(s) disclosed herein, such as 2-(2-methoxybenzylidene)-1-indan-one; n-(4-arsonophenyl)glycine; 1,2-benzenedicarboxylic acid, 1-(1-methylheptyl)ester; (4′-hydroxybiphenyl-4-yl) (phenyl)methanone; 2,2-dimethylchroman-6-carboxylic acid, (4,7-dihydroxy-8-methyl-2-oxo-2h-chromen-3-yl)amide; ethyl 2-((4-chlorophenyl)thio)-1,3-benzothiazol-6-yl carbamate; ethyl (2-(azepan-1-yl)benzo[d]thiazol-6-yl) carbamate; porfiromycin; 1,3-benzodioxol-5-yl-[4-(3,4,5-trimethoxybenzoyl)-3-furyl]methanone; tricinolone acetophenonide; 2,4-bis(3,4-dimethoxyphenyl)-4h-pyrano[3,2-c]chromen-5-one; methyl 5-fluoro-4-methoxy-2,6-dioxohexahydro-5-pyrimidine carboxylate; 5-(naphthalen-1-yl)-1-phenyl-1h-tetrazole; 5-(2-phenylquinolin-4-yl)-1,3,4-oxadiazol-2-ol; n-[2,4,5-trimethyl-4-(trichloromethyl)cyclohexa-2,5-dien-1-ylidene]hydroxylamine; 4-benzoyl-3,4-dihydro-benzo[f]quinoline-3-carbonitrile; 2-nitro-3-phenylspiro[cyclopropane-1,9′-fluorene]; 3-[4-(furan-2-ylmethyl)-5-sulfanylidene-1,2,4-dithiazolidin-3-ylidene]-1,1-dimethyl-thiourea; (6-acetamido-7-methyl-5,8-dioxo-2,3-dihydro-1h-pyrrolo[1,2-a]benzimidazol-3-yl)2-methoxyacetate; 5-iodo-1h-indole-2,3-dione; 4,5-dihydro-1,2,9,10-tetramethoxy dibenzo[de,g]quinoline-6-carboxylic acid, ethyl ester; [2,6-bis(2,4-dimethylphenyl)-4-(2-methoxyacetyl)oxy-phenyl]2-methoxyacetate; 5,11-dimethyl-2-(2-piperidin-1-ylethyl)-6h-pyrido[4,3-b]carbazol-2-ium-9-ol; 2-[3-[[4-[(3-nitroacridin-9-yl)amino]phenyl]sulfamoyl]propyl]guanidine; 1-[[2-(dimethylamino)ethyl]amino]-7-hydroxy-4-methyl-9h-thioxanthen-9-one; 5-amino-1h-1,2,4-triazole-3-carboxylic acid, methyl ester; methyl n-cyano-n′-prop-2-en-1-ylcarbamimidothioate; 5,7-dinitro-8-quinolinol; 5-nitrosoquinolin-8-ol; cantharidin; 1,7-diaminoacridine; 3-methyl-3-(1-naphthyl)-2-benzofuran-1(3h)-one; dichlorolapachol; lycobetaine; 6-(1-aziridinyl)-2,3-dihydro-3-(propionyl)-7-methyl-1h-pyrrolo[1,8]-dione; 4-nitroestrone 3-methyl ether; 5,11-dimethyl-6h-pyrido[4,3-b]carbazole-1-carboxamide hydrochloride; 5-methoxysterigmatocysin; (6-acetamido-7-methyl-5,8-dioxo-2,3-dihydro-1h-pyrrolo[1,2-a]benzimidazol-3-yl)2-methoxyacetate; horminon; 7′,8′-dimethyl-2′-oxo-4′,4a′,6a′,7′-tetrahydro-2′h-spiro[oxirane-2,1′-pentaleno[1,6a-c]pyran]-5′-carboxylate; nybomycin acetate; 5h-[1,6]indeno[1,2-c]isoquinoline-5,12-dione; 2,3-dimethoxy-6-methyl-nitidine; iproplatin; 3-[(deoxyhexosyl)oxy]-2-(3,4-di-hydroxyphenyl)-6,8-dihdroxy-4h-1-benzopyran-4-one; 2-o-benzyl 8-o-methyl 3-(4-methylphenyl)sulfonyl-4,5-dioxo-6h-pyrrolo[3,2-e]indole-2,8-dicarboxylate; 6-bromo-5,8-dihydroxy-7-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]naphthalene-1,4-dione; 5-methylbenzo[c]phenanthridin-5-ium-2,3,8,9-tetrol; (6-acetyl-4-oxo-1,3-diphenyl-2-sulfanylidenethieno[2,3-d]pyrimidin-5-yl)-2,4-dichlorobenzoate; n—[c-[4-[bis(2-cyanoethyl)amino]-2-methylphenyl]-n-(4-methylanilino)carbonimidoyl]imino-4-methylbenzamide; gelcohol; curcumin; tirandamycin; noscapine; aristolochic acid; himbacine; fumagillin; fumitremorgin c; physalin b; derivatives, or salt thereof, for use in bone growth processes.
Emory University


05/28/15
20150147499 

Heat shrinkable tube and system including heat-recovered heat shrinkable tubing


A heat shrinkable tube and system including a heat-recovered heat shrinkable tube are disclosed. The heat shrinkable tube is an extrusion and expansion of a blend comprising a polyethylene terephthalate copolymer.
Tyco Electronics Corporation


05/28/15
20150147350 

Method of treating cancer with megea3 immunotherapeutic with braf inhibitor and/or mek inhibitor


A combination of anti-neoplastic agents that provides increased activity over monotherapy, or in some cases at least an unexpected lack of negative interaction. In particular, the drug combination that includes a mage-a3 immunotherapeutic, in combination with a b-raf inhibitor, particularly n-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide, or a pharmaceutically acceptable salt thereof, and/or a mek inhibitor, particularly n-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethy; -2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof is described..
Glaxosmithkline Llc


05/28/15
20150144850 

Metal oxide dispersion and uses thereof


The present invention provides a metal oxide dispersion comprises a metal oxide, a millbase and a dispersant. The dispersant in the metal oxide is selected from a group consisting of a phosphoric acid polyester copolymer, a trimethoxysilane compound, a triethoxysilanes compound, dimethylamino ethyl methacrylate (dmaema) and a combination thereof, and the dispersion is substantially free of water.
Novartis Ag


05/21/15
20150141695 

Methods of producing para-xylene and terephthalic acid


The present disclosure provides methods to produce para-xylene, toluene, and other compounds from renewable sources (e.g., cellulose, hemicellulose, starch, sugar) and ethylene in the presence of a catalyst. For example, cellulose and/or hemicellulose may be converted into 2,5-dimethylfuran (dmf), which may be converted into para-xylene by cycloaddition of ethylene to dmf.
Micromidas, Inc.


05/21/15
20150141690 

Process for making dimethyl carbonate


An eco-friendly process for making dimethyl carbonate comprising contacting methanol with carbon dioxide in the presence of a solid, calcined catalyst derived from zirconium phosphonate catalyst having molecular formula: zr(x)2-nyn.mh2o where x refers to phosphonate, y refers to hpo42− or hpo32−, n varies from 0.2 to 1.8 and m varies from 0 to 5, is disclosed.. .
Council Of Scientific & Industrial Research


05/21/15
20150141631 

Pyrazole derivative and use thereof for medical purposes


The present invention provides pyrazole derivatives, uses thereof for medical purposes and so on. More particularly, the present invention relates to pharmaceuticals useful for the prevention or treatment of constipation, which comprise as an active ingredient 3-(3-{4-[3-(β-d-glucopyranosyloxy)-5-isopropyl-1h-pyrazol-4-ylmethyl]-3-methylphenoxy}propylamino)-2,2-dimethylpropionamide, or a pharmaceutically acceptable salt thereof.
Kissei Pharmaceutical Co., Ltd.


05/21/15
20150141618 

Solution-dyed protein fiber and producing same


A solution-dyed protein fiber of the present invention includes 0-100 mass % of silk fibroin and 100-0 mass % of a polypeptide derived from spider silk proteins when the protein fiber is assumed to be 100 mass %, wherein the solution-dyed protein fiber contains a solution-dyeing colorant. The fiber is obtained by: dissolving or dispersing a solution-dyeing colorant in a solvent used for a spinning solution or in dimethyl sulfoxide, thereby preparing a coloring liquid; adding a solvent to the coloring liquid in an amount necessary for a spinning solution; adding and dissolving protein powder into the solvent, thereby preparing a spinning solution; and subjecting the spinning solution to wet spinning or dry-wet spinning.
Spiber Inc.


05/21/15
20150141502 

Inhibition of leukemic stem cells by pp2a activating agents


A method of inhibiting the growth of leukemic hematopoietic stem cells in a subject with leukemia is described. The method includes administering a therapeutically effective amount of a composition including a compound of formula i: i wherein r1 is independently selected from hydrogen and methyl; r2 is selected from the group consisting of 4,8-dimethyl-non-1-enyl, 4,8-dimethyl-nonyl, non-1-enyl, and nonanyl groups; x is a carboxyl, phosphonic, or sulfonic moiety, and n is an integer from 1 to 6, or a compound of formula ii: ii wherein r1 is a c6-c12 alkyl or c6-c12 alkoxy group; r2 is independently selected from the group consisting of hydrogen, methoxy, and hydroxyl; and r3 is an alkyl or cycloalkyl group; or a pharmaceutically acceptable salt thereof..
Ohio State Innvation Foundation


05/21/15
20150141460 

Anti-inflammatory compositions


The invention relates to 3-(2′,2′-dimethylpropanoylamino)-tetrahydropyridin-2-one, and its pharmaceutical compositions and their use as a medicament intended to prevent or treat inflammatory disorders.. .
Cambridge Enterprise Limited


05/21/15
20150141253 

Crystalline form b of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione


The present invention relates to a novel crystalline form b of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione the invention also relates to a process for the production of this crystalline form and formulations for plant protection which contains the novel crystalline form of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2h-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione.. .
Basf Se


05/21/15
20150140631 

Production of volatile dienes by enzymatic dehydration of light alkenols


Described is a method for generating conjugated dienes through a biological process. More specifically, the application describes a method for producing conjugated dienes (for example butadiene, isoprene or dimethylbutadiene) from light alkenols via enzymatic dehydration, in particular by making use of an alkenol dehydratase..
Scientist Of Fortune, S.a.


05/21/15
20150139931 

Organopolysiloxane graft polymer


The present invention relates to a organopolysiloxane graft polymer including an organopolysiloxane segment as a main chain thereof and an unsaturated monomer-derived polymer segment as a side chain thereof, in which the unsaturated monomer-derived polymer segment contains a repeating unit derived from n,n-dimethyl acrylamide in an amount of not less than 50% by mass and not more than 100% by mass, and a content of the organopolysiloxane segment in the organopolysiloxane graft polymer is not less than 10% by mass and not more than 70% by mass.. .
Kao Corporation


05/21/15
20150138673 

Method for manufacturing a magnetic tape head using an ink mask formed by printing


A method for forming a protective overcoat onto a tape bearing surface of a tape head used for magnetic tape recording. In order to ensure optimal surface tension and liftoff properties of the ink mask, the tape bearing surface is treated with a first application of ethanol, followed by an application of polydimethylsiloxane, followed by a second application of ethanol.
Hgst Netherlands B.v.


05/21/15
20150137029 

Electrode mixture


The present invention aims to provide an electrode mixture which shows little change in viscosity even after 24 hours from the preparation of the mixture and enables production of an electrode having a high electrode density and excellent flexibility and is capable of giving excellent electric properties to the resulting cell. The present invention relates to an electrode mixture including a powdery electrode material; a binder; and an organic solvent, the binder including a fluorine-containing polymer including a polymer unit based on vinylidene fluoride and a polymer unit based on tetrafluoroethylene, the fluorine-containing polymer including the polymer unit based on vinylidene fluoride in an amount of 80.0 to 89.0 mol % based on all the polymer units, and the organic solvent being n-methyl-2-pyrolidone and/or n,n-dimethylacetamide..
Daikin Industries, Ltd.


05/21/15
20150136658 

Process for removing ash and heavy hydrocarbons from coal tar


A process for removing ash and heavy hydrocarbon compounds from coal is described. The coal feed, the coal tar stream, or a coal tar fraction is contacted with a solvent to dissolve a soluble portion of the coal tar stream, the ash and heavy hydrocarbons being insoluble in the solvent, the solvent selected from the group consisting of dimethyl sulfoxide, sulfolane, dimethyl formamide, glyme, diglyme, ionic liquids, and combinations thereof, with the proviso that an anion of the ionic liquid is not a dialkylphosphate..
Uop Llc


05/14/15
20150133699 

Process for the preparation of methanol and methanol-derived products from carbon oxides


A process for the preparation of methanol having the process a carbon oxides per-pass conversion equal to or higher than 65%, and a selectivity to methanol formation equal to or higher than 75% by submitting carbon dioxide, carbon monoxide or a mixture of carbon monoxide and carbon dioxide to a hydrogenation reaction using a specific metal compound and specific reaction conditions of temperature, pressure, space velocity and a specific range of molar ratio of hydrogen to carbon dioxide, of hydrogen to carbon monoxide, or of hydrogen to the mixture of carbon monoxide and carbon dioxide. It further relates to a process for converting the methanol obtained into dimethyl ether or into a mixture of (c2-c8)alkene and (c1-c8)alkane..

05/14/15
20150133659 

(e)-1-(5-methoxy-2,2-dimethyl-2h-chromen-8-yl)-3-(4-methoxyphenyl)prop-2-en-1-one and analogs thereof, as well as preparation method and use thereof


The present invention relates to millepachine ((e)-1-(5-methoxy-2,2-dimethyl-2h-chromen-8-yl)-3-(4-methoxyphenyl)prop-2-en-1-one) and its analogues. The present invention provides methods for preparing these compounds, pharmaceutical compositions including these compounds, and methods of treating diseases utilizing pharmaceutical compositions including these compounds..

05/14/15
20150133654 

Novel methods and intermediates for the preparation of (4bs,5ar)-12-cyclohexyl-n-(n,n-dimethylsulfamoyl)-3-methoxy-5a-((1r,5s)-3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)-4b,5,5a,6-tetrahydrobenzo [3,4]cyclopropa[5,6]azepino[1,2-a]indole-9-carboxamide


The present invention provides methods and intermediates for the preparation of (1ar,12bs)-8-cyclohexyl-11-fluoro-n-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,12b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide (formula i), including pharmaceutically acceptable salts. The compound has activity against hepatitis c virus (hcv) and may be useful in treating those infected with hcv..



Popular terms: [SEARCH]

Dimethyl topics: Physiologic, Hydrochloric Acid, Fresnel Zone, Aberration, Ophthalmic, Liquid Crystal, Imaging System, Pharmaceutically Acceptable Salt, Pharmaceutically Acceptable Salts, Chloric Acid, Tartaric Acid, Fumaric Acid, Antagonist, Bradykinin, Enantiomer

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Dimethyl for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dimethyl with additional patents listed. Browse our RSS directory or Search for other possible listings.


0.4689

4639

0 - 1 - 102